Hughes Financial Services’s Zenas BioPharma ZBIO Stock Holding History

Hughes Financial Services’s Portfolio ZBIO Stock Details ZBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25	Buy	+1	New	+$20	﹤0.01%	1736

Other funds holding ZBIO

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Mirae Asset Global Investments

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Torren Management San Diego, California $197M AUM

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Hughes Financial Services's ZBIO Position: Q2 2026 in Review

Hughes Financial Services opened a new position in Zenas BioPharma (ZBIO) in Q2 2026: 1 share worth $25. The stake represents ﹤0.01% of the portfolio and ranks #1736 among its holdings.

9 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

Hughes Financial Services held 1 share of Zenas BioPharma worth $25 as of Q2 2026.
Zenas BioPharma was a new Hughes Financial Services position in Q2 2026.
Zenas BioPharma made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1736 holding.
9 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.